Top Markets
#1 Fake World Assets Fake World Assets +11.59%
#2 TENDIES TENDIES +4.80%
#3 GoPlus Security GoPlus Security +4.67%
#4 Everything Everything +3.70%
#5 TronBank TronBank +3.67%
#6 Janction Janction +3.26%
#7 Prom Prom +3.26%
#8 Tutorial Tutorial +3.00%
#9 DUSK Network DUSK Network +2.91%
#10 Humanity Humanity +2.36%
Coin of the day
Fake World Assets Fake World Assets
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Rangering i aksjer #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Aksjekurs
$0.617
Sist synkronisert: 2024-10-14
Markedsverdi
$6.13M
Endring (1 dag)
0.49%
Endring (1 år)
0.00%
Land
US
Handel Kineta, Inc. (KA)

Kategori

Healthcare
Antall utestående aksjer for Kineta, Inc. (KA)
Antall utestående aksjer per March 2025: 12.90M
Ifølge Kineta, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 12.90M. Ved slutten av December 2023 hadde selskapet 11.05M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Kineta, Inc. (KA) fra 2015 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 12.90M 6.63%
2024 12.10M 9.46%
2023 11.05M 124.40%
2022 4.93M 235.32%
2021 1.47M 336.81%
2020 336.31K -7.93%
2019 365.28K 32.85%
2018 274.97K 51.51%
2017 181.49K 35.44%
2016 134.00K -24.63%
2015 177.78K 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 1,867.91%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 381.98%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE